MSS2024
HYBRID

14 - 16 September 2026

Bled, Slovenia

It is our sincere pleasure to invite you to participate in MSS2026. Join us!



Our symposium explores purification solutions from development to manufacturing, integrating advanced analytics for gene therapies, vaccines, and biological products like plasma, proteins, and enzymes. Covering all processing stages – from upstream to downstream – it offers a hybrid format for both in-person and virtual engagement.

MSS2024 Speakers

Dan Peer

NeoVac, UK

Next Generation Lipid Nanoparticles for RNA Vaccines and Therapeutics

Justina Martinkiene

AstraZeneca, UK

Enabling CIMmultus DEAE columns at scale for plasmid DNA capture

Zoltán Kis

University of Sheffield, UK

Innovating and digitalising mRNA vaccine and therapeutics production processes

Tjaša Legen

BioNTech, Germany

Manufacturing of mRNA for pre-clinical and clinical studies

Stefano Menegatti

North Carolina State University, USA

GET+VVIRAL: a purification toolbox for the gene-editing tools and viral vectors

Chantal Pichon

INSERM, France

Bioproduction of messenger RNA: key benefits and challenges

Be the first to know about updates
stay informed

Connect with us on LinkedIn to get updates about the event, special discounts and call for abstracts.

The best of MSS2024 on-demand

Take advantage of the opportunity to listen to recordings from MSS2024. Register to hear experts share their insights and knowledge this summer.

The first recording is free of charge!

mss2024 overview

Get some insight about our past events and hear the testimonials of our past attendees.

Previous event highlights

Highlights